Abstract:Meng Zhang, Fuqiang Zhang, Te Liu, Pu Shao, Lian Duan, Jun Yan, Xupeng Mu, * Jinlan Jiang * Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, People's Republic of China *These authors contributed equally to this work Correspondence: Jinlan Jiang; Xupeng Mu Scientific Research Center, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun 130033, Jilin, People's Republic of China Email jiangjinlan@jlu.edu.cn; muxupeng@jlu.edu.cn Purpose: Nanoparticle (NP)-based chemo-photothermal therapy (CPT) has been shown to be a promising non-invasive approach for antitumor treatment. However, NPs must overcome the limitations of opsonization, clearance of the reticuloendothelial system, and ineffective targeting of tumor tissue sites. To solve these problems, stem cell membrane (SCM)-camouflaged polydopamine nanoparticles (PDA@SCM NPs) carrying the hydrophobic anticancer drug 7-ethyl-10-hydroxycamptothecin (SN38) were constructed for CPT of malignant bone tumors. Methods: We developed umbilical-cord mesenchymal stem cell membrane-coated polydopamine nanoparticles encapsulating SN38 (PDA-SN38@SCM NPs) as an efficient tumor-targeting drug-delivery platform for CPT of malignant bone tumors. We characterized PDA@SCM NPs and evaluated the biocompatibility and anti-phagocytosis properties of PDA@SCM NPs. The antitumor activity of PDA-SN38@SCM NPs was evaluated in MG63 lines and an MG63 xenograft model in mice. Results: Synthesized PDA-SN38@SCM NPs retained an excellent photothermal effect after SN38 loading. The drug release of PDA-SN38@SCM NPs could be triggered by near-infrared irradiation and an acidic stimulus. PDA@SCM NPs exhibited lower nonspecific macrophage uptake, longer retention in blood, and more effective accumulation at tumor sites than that shown by PDA NPs. Confocal laser scanning microscopy (CLSM) and flow cytometry showed that MG63 cells took up more PDA-SN38@SCM NPs than PDA-SN38 NPs. In vitro and in vivo antitumor studies demonstrated the outstanding performance of PDA-SN38@SCM NPs in synergistic CPT for bone tumors. Conclusion: PDA-SN38@SCM NPs demonstrated an extraordinary synergistic CPT effect and could be a promising strategy for the treatment of malignant bone tumors. Keywords: stem cell membrane, polydopamine nanoparticles, chemo-photothermal therapy

Polydopamine-modified ZIF-8 Nanoparticles As a Drug Carrier for Combined Chemo-Photothermal Osteosarcoma Therapy

Polydopamine-Functionalized CA-(PCL-ran-PLA) Nanoparticles for Target Delivery of Docetaxel and Chemo-photothermal Therapy of Breast Cancer.

An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy

Photothermally Reinforced Chemodynamic Therapy in the Treatment of Osteosarcoma by Polydopamine-Modified, Copper Peroxide Loaded ZIF8 Nanoparticles

Iron-polydopamine Coated Multifunctional Nanoparticle SiO2@PDA/Fe3+- FA Mediated Low Temperature Photothermal for Chemodynamic Therapy of Cisplatin-Insensitive Osteosarcoma

Polydopamine-drug conjugate nanocomposites based on ZIF-8 for targeted cancer photothermal-chemotherapy

Biomimetic Polydopamine-Modified Silk Fibroin/Curcumin Nanofibrous Scaffolds for Chemo-photothermal Therapy of Bone Tumor

Ph/thermal Dual-Responsive Multifunctional Drug Delivery System for Effective Photoacoustic Imaging-Guided Tumor Chemo/photothermal Therapy.

ZIF-8 coated gold nanospheres: a multi-responsive drug delivery system promoting the killing effect of photothermal therapy against osteosarcoma cells

Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors

Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma

Oligopeptide modified ICG/Cisplatin@CaCO 3 for targeted osteosarcoma NIR-II imaging guided multimodal therapy

Mitochondria targeted biomimetic platform for chemo/photodynamic combination therapy against osteosarcoma

Hyaluronic Acid Conjugated Polydopamine Functionalized Mesoporous Silica Nanoparticles for Synergistic Targeted Chemo-Photothermal Therapy

Anti-osteosarcoma Trimodal Synergistic Therapy Using NiFe-LDH and MXene Nanocomposite for Enhanced Biocompatibility and Efficacy

Synthesis of dual-stimuli responsive metal organic framework-coated iridium oxide nanocomposite functionalized with tumor targeting albumin-folate for synergistic photodynamic/photothermal cancer therapy

Dual peptide-engineered and gadolinium-doped polydopamine particles as targeted nanotheranostics for the treatment of osteosarcoma and related osteolysis

A Photosensitizer-Loaded Polydopamine Nanomedicine Agent for Synergistic Photodynamic and Photothermal Therapy

Engineering PDA-coated CM-CS nanoparticles for photothermo-chemotherapy of osteosarcoma and bone regeneration